▲ S&P 500 +---% | ▲ Stock Advisor +---% Join The Motley Fool

Accessibility Log In Help

Daily Stock Gainers Daily Stock Losers Most Active Stocks

Daily Stock Gainers Daily Stock Losers Most Active Stocks

James Halley

XMFjimhalley

@jimhalley

Recent Articles by James Halley

novartisandmeridian

Mar 26, 2023 by James Halley

3 Healthcare Spinoffs Worth a Look, But 1 Has the Best Long-Term Potential

These three spinoffs are already profitable.

scientist sterilizing test tubes lab science

Mar 25, 2023 by James Halley

2 Clinical Research Stocks That Could Grow by More Than 10% This Year, and 1 to Watch

These companies strive to bring down the cost of developing new therapies.

nurse and doctors in masks discussing chart

Mar 24, 2023 by James Halley

Why Shares of Orchestra BioMed Jumped This Week

The company is considered one of the top medical device start-ups this year.

healthcare lab treatment research scientist

Mar 24, 2023 by James Halley

Why Shares of Immuneering Jumped This Week

Immuneering is ready to share information regarding its lead therapy.

Axesome

Mar 24, 2023 by James Halley

Why Shares of 89bio Soared This Week

The company released positive results for its lead therapy.

medstocks

Mar 23, 2023 by James Halley

Why Shares of Regeneron Are Rising Thursday

Regeneron released positive phase 3 trial results for its therapy Dupixent.

pharmacy pharmacist drug medicine prescription (1)

Mar 23, 2023 by James Halley

3 Things About AbbVie That Smart Investors Know

Thinking long-term could pay off now for AbbVie investors.

Pharmaceutical factory worker

Mar 22, 2023 by James Halley

Is It Too Late to Buy McKesson Stock?

The healthcare supplier has seen its shares climb 15% over the past year.

DNA sequencing genome science lab

Mar 22, 2023 by James Halley

Why Shares of GeneDx Dropped Wednesday

The potential of a reverse split concerned investors.

therapist Rorschach inkblot test

Mar 22, 2023 by James Halley

Why Shares of Karuna Therapeutics Were Up Wednesday

The clinical-stage biotech announced positive trial results for its lead therapy.

Physician monitoring patients onscreen vitals

Mar 21, 2023 by James Halley

Why Shares of Roivant Sciences Were Down Tuesday

After a run-up last week prompted by positive clinical trial results, the stock has given back its recent gains.

Physician going over results with patient (1)

Mar 21, 2023 by James Halley

2 Better Healthcare REITs Than Medical Properties Trust

Healthcare REITs are a solid choice for finding higher dividend yields -- if you choose the right one.

veterinarian works with dog

Mar 20, 2023 by James Halley

Why Shares of Zomedica Were Zooming Monday

Investors bought back into the stock after it fell to its lowest point in two months.

lab research scientists science test tube experiement women in STEM

Mar 20, 2023 by James Halley

Is Roche a Buy Now?

Roche focuses on the long-term.

surgeons surgery medical IV syringe (1)

Mar 18, 2023 by James Halley

Ready to Buy the Dip? Johnson & Johnson Stock Is a Smart Buy

Close to its 52-week low, this healthcare stalwart remains a good purchase.

Vaccinated senior woman flexing biceps muscle with 'Got vaccinated' sticker

Mar 17, 2023 by James Halley

Better RSV Vaccine Stock: Pfizer, GSK, or Moderna?

An approved RSV vaccine could be the next big thing for these companies.

Senior Patient Rests on the Bed, Nurse in Ward Does Checkup

Mar 16, 2023 by James Halley

Why Deciphera Pharmaceuticals Stock Jumped This Week

The company's lead therapy received an FDA Breakthrough Therapy designation.

abbvie

Mar 16, 2023 by James Halley

Why Shares of Inari Medical Rose This Week

The medical equipment maker's stock has climbed by $10 a share since the start of the month.

DNA genetic sequencing biotech (1)

Mar 16, 2023 by James Halley

Why Shares of MacroGenics Climbed Thursday

The cancer-focused biotech delivered a strong earnings report.

pharmacy pharmacist drug medicine prescription (1)

Mar 16, 2023 by James Halley

2 Healthcare Dividend Stocks That Hit the Sweet Spot

High yields, consistent revenue growth, and safe payout ratios can go together.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services